ANNX Stock Analysis: Buy, Sell, or Hold?
ANNX - Annexon, Inc. Common Stock
$5.10
-0.17 (-3.32%)
▼
5d:
-2.39%
30d:
-8.2%
90d:
-13.2%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
9d
Smart Money Accumulation
None View Scanner →
Strength: 3.6/10
Get Alerted When ANNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ANNX shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: ANNX shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: ANNX is currently trading at $5.09, which is considered oversold relative to its 30-day fair value range of $5.12 to $5.91.
Technical Outlook: Technically, ANNX is in a downtrend. Immediate support is located at $4.76, while resistance sits at $5.92. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.56 (+166.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ANNX is in a downtrend. Immediate support is located at $4.76, while resistance sits at $5.92. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.56 (+166.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.12 -
$5.91
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 166.1% below Wall St target ($13.56)
Trading Range Analysis
30-Day Trading Range
$5.12 -
$5.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.76
Resistance Level
$5.92
Current Trend
Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.30
Wall Street Target
$13.56
(+166.1%)
Share & Embed Analysis
Last updated: August 03, 2026 12:14 AM ET
Data refreshes hourly during market hours. Next update: 1:14 AM
Data refreshes hourly during market hours. Next update: 1:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANNX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
William H Carson
BUY
8000 shares
2026-04-10
William H Carson
BUY
8000 shares
2026-03-10
Dean Richard Artis
SELL
5290 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$33 | 58 HOLD |
